Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation
Latest Information Update: 22 Dec 2023
Price :
$35 *
At a glance
- Drugs Fludarabine (Primary) ; Melphalan (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions; Therapeutic Use
- 14 Dec 2023 Planned End Date changed from 1 Sep 2025 to 16 Nov 2025.
- 14 Dec 2023 Planned primary completion date changed from 1 Sep 2024 to 16 Nov 2025.
- 14 Aug 2023 Planned End Date changed from 1 Jul 2024 to 1 Sep 2025.